Lawsuit Over Delays Might Change the Case for Investing in ATS (TSX:ATS)

• In a recent development, Andersen Corp. has filed a lawsuit against ATS Corp., alleging significant delays and financial losses due to ATS's inability to deliver automation equipment for Andersen's Iowa plant on schedule.
• This litigation draws attention to potential project management and quality control challenges at ATS, highlighting operational risks that may affect reputation and future business opportunities.
• We'll assess how the alleged project delays and resulting lawsuit could alter ATS's long-term growth and margin expectations.

We've found 19 US stocks that are forecast to pay a dividend yield of over 6% next year. See the full list for free.

ATS Investment Narrative Recap

To be a shareholder in ATS, you need to be confident in the ongoing automation trend driven by labor shortages and manufacturing complexity, with order backlog growth offering revenue visibility. The recent lawsuit from Andersen Corp. spotlights project management and execution risk, which could influence investor confidence if operational disruptions impact critical near-term customer deliveries, but does not materially diminish the fundamental short-term catalyst: rising North American automation demand. The biggest risk remains execution, especially as ATS integrates prior acquisitions amid ongoing macro uncertainty and fluctuating order volumes.

The most relevant recent announcement is ATS’s Q1 FY2026 results, where the company posted CAD 736.72 million in sales but continued to see pressure on profitability with net income down to CAD 24.12 million. This provides a snapshot of ongoing integration challenges and margin headwinds, now compounded by public scrutiny following the Andersen dispute, as the market weighs management’s ability to deliver on cost control and promised efficiency gains while sustaining the automation revenue pipeline. In contrast, ongoing changes in executive leadership and project execution oversight may prove to be a key area for investors to watch next, especially as...

Read the full narrative on ATS (it's free!)

ATS' narrative projects CA$3.5 billion revenue and CA$580.2 million earnings by 2028. This requires 10.5% yearly revenue growth and a CA$619.4 million earnings increase from CA$-39.2 million.

Uncover how ATS' forecasts yield a CA$47.80 fair value, a 27% upside to its current price.

Exploring Other Perspectives

Four members of the Simply Wall St Community placed ATS’s fair value between CA$16.51 and CA$47.80, underscoring a wide range of outlooks and price targets. With project execution now under scrutiny due to recent customer litigation, it is clear you can find sharply different perspectives on where the company’s fortunes go from here, review more in the Community’s detailed viewpoints.

Explore 4 other fair value estimates on ATS - why the stock might be worth as much as 27% more than the current price!

Build Your Own ATS Narrative

Disagree with existing narratives? Create your own in under 3 minutes - extraordinary investment returns rarely come from following the herd.

• A great starting point for your ATS research is our analysis highlighting 3 key rewards and 1 important warning sign that could impact your investment decision.
• Our free ATS research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate ATS' overall financial health at a glance.

Contemplating Other Strategies?

Our daily scans reveal stocks with breakout potential. Don't miss this chance:

• AI is about to change healthcare. These 32 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
• Find companies with promising cash flow potential yet trading below their fair value.
• The best AI stocks today may lie beyond giants like Nvidia and Microsoft. Find the next big opportunity with these 25 smaller AI-focused companies with strong growth potential through early-stage innovation in machine learning, automation, and data intelligence that could fund your retirement.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com